T2 BIOSYSTEMS INC - COM (TTOO)

CUSIP: 89853L104

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Equity / COM
Total 13F shares
14,877,864
Share change
+3,473,937
Total reported value
$18,905,027
Put/Call ratio
88%
Price per share
$1.27
Number of holders
47
Value change
+$4,694,736
Number of buys
26
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 89853L104?
CUSIP 89853L104 identifies TTOO - T2 BIOSYSTEMS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of T2 BIOSYSTEMS INC - COM (TTOO) as of Q2 2020

As of 30 Jun 2020, T2 BIOSYSTEMS INC - COM (TTOO) was held by 47 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,877,864 shares. The largest 10 holders included VANGUARD GROUP INC, GOLDMAN SACHS GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, GAGNON SECURITIES LLC, BRIDGEWAY CAPITAL MANAGEMENT INC, Squarepoint Ops LLC, NORTHERN TRUST CORP, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and CITADEL ADVISORS LLC. This page lists 47 institutional shareholders reporting positions in this security for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.